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Epigenetic and molecular mechanisms underlying gene expression in porcine 
skeletal muscle and satellite cells  
 
Epigenetic studies have been conducted in association with skeletal muscle only during 
the last years. We performed in vivo study in skeletal muscle and in vitro study in 
satellite cells with the aims to understand the epigenetic mechanisms regulating muscle 
gene expression. Duroc and Pietrain pigs, representing two extremes in skeletal muscle 
phenotypes, were selected for the in vivo study. Myogenic factor 6 (MYF6) was 
selected as one of the contributing factors to the postnatal breed-specific muscle 
properties in two breed pigs. Quantitative real time PCR (qRT-PCR) and Western 
blotting results revealed that mRNA and protein expression of MYF6 were dramatically 
higher in Pietrain pigs compared to Duroc pigs and suggested breed-specific expression. 
Variations in DNA methylation of the MYF6 gene 5´-regulatory region, particularly 
within important transcription factor binding elements, are shown to occur between 
breeds. However, in Pietrains pigs, higher expression of MYF6 is not consistent with 
hypermethylation status, but concurrent with enriched E2F1 expression. In addition to 
its practical implications, this work extends our understanding the role of epigenetic 
mechanism in postnatal pigs. Satellite cells, acting as the muscle stem cells to support 
postnatal muscle growth, were selected for the in vitro study. Sulforaphane (SFN), a 
novel and natural histone deacetylase (HDAC) inhibitor, was selected as the treatment 
epigenetic reagent. Apart from SFN, we also employed the typical epigenetic reagents 
5-aza-2′-deoxycytidine (5-aza-dC) and trichostatin (TSA). Distinguished from TSA, 
SFN and 5-aza-dC remarkably suppress myostatin (MSTN) expression and inhibit 
HDAC activity as well as DNA methyltransferase (DNMT) expression. SFN, 5-aza-dC 
and TSA exhibited differential mechanisms to repress MSTN expression and negative 
regulators of MSTN pathway. Deregulated miRNA may be excluded from epigenetic 
repression of MSTN. However, epigenetic suppression of MSTN by 5-aza-dC and SFN 
is associated with the decreased myoblast determination protein (MyoD) expression, 
reduced binding of MyoD on MSTN promoter and hypoacetylation in MyoD binding 
site. These observations manifest a novel mechanism for manipulation of muscle cell 
phenotypes.  
 
 
  
Epigenetische und molekulare Mechanismen die der Genexpression in porcinen 
Skelettmuskel und Satellitenzellen zugrunde liegen  
 
 
In den letzten Jahren wurden epigenetische Studien nur in Zusammenhang mit der 
Skelettmuskulatur umgesetzt. Wir hingegen führten in vivo Studien an der 
Skelettmuskulatur und in vitro Studien in Satellitenzellen durch, mit dem Ziel ein 
besseres Verständnis der epigenetischen Mechanismen zu erlangen, die einen Effekt auf 
die Regulierung von relevanten Muskelgenen haben könnten. Für die in vitro Studie 
wurden Duroc und Pietrain Schweine, die sich in ihrem Phänotyp der Skelettmuskulatur 
stark unterscheiden, ausgesucht. Myogener Faktor 6 (Myf6) gilt als ein entscheidender 
Faktor für postnatale rassenspezifische Muskeleigenschaften in zwei Rassen. 
Quantitative real time PCR (qRT-PCR) und Western Blot Ergebnisse zeigten, dass die 
Myf6 mRNA- und Protein-Expression dramatisch höher bei Pietrain im Vergleich zu 
Duroc Schweinen waren. Dieses kann auf eine rassenspezifische Expression hindeuten. 
Variationen in der DNA-Methylierung des Myf6 Gens in der 5´regulierenden Region, 
speziell innerhalb wichtiger Transkriptionsfaktorbindeelementes, konnten zwischen den 
Rassen ermittelt werden. Doch zeigte sich bei der Rasse Pietrain, dass eine höhere 
Expression von Myf6 nicht übereinstimmend mit dem Hypermethylierungsstatus ist,  
sondern mit einer hohen E2F1 Expression konkurriert. Zusätzlich zu den praktischen 
Implikationen erweitert diese Studie unser Verständnis über die Rolle des 
epigenetischen Mechanismus in postnatalen Schweinen. Für die in vitro Studie wurden 
Satellitenzellen als Muskelstammzellen, die das postnatale Muskelwachstum 
unterstützen, verwendet. Sulforaphane (SFN), ein neuartiger und natürlicher Histon 
Deacetylase (HDAC) Inhibitor, wurde als ein epigenetisches Behandlungsreagenz 
ausgewählt. Neben SFN setzten wir weitere typische epigenetische Reagenzien wie 5-
Aza-2′-deoxycytidine (5-aza-dC) und Trichostatin (TSA) ein. Im Gegensatz zu TSA 
zeigen SFN und 5-aza-dC die Eigenschaft, nicht nur die HDAC Aktivität zu 
unterdrücken sondern auch die DNA-Methyltransferase Expression (DNMT) und die 
Expression von Myostatin (MSTN). SFN, 5-aza-dC und TSA weisen unterschiedliche 
Mechanismen auf, um die Expression von MSTN und negativen Regulatoren des 
MSTN Signalwegs zu unterdrücken. Deregulierte miRNA wird vielleicht von der 
epigenetischen Unterdrückung von MSTN ausgenommen. Jedoch kann die 
epigenetische Unterdrückung von MSTN durch 5-aza-dC und SFN mit einer 
verringerten Myoblast Determination Protein (MyoD) Expression assoziiert werden 
durch reduzierte Bindung von MyoD an den MSTN Promotor und Hypoacetylierung 
der MyoD Bindungsstelle. Diese Beobachtungen manifestieren einen neuartigen 
Mechanismus zur Manipulation des Muskelzellphänotypen. 
V 
Contents    
 
   
Abstract  III 
Zusammenfassung  IV 
List of abbreviations  VI 
List of tables  IX 
List of figures  X 
 
   
1 Overview   
1.1 Introduction   1 
1.2 Materials and methods  7 
1.3 Results  10 
1.4 Conclusion   11 
1.5 References  12 
 
   
2 Annex    
2.1 Chapter 1  
Molecular mechanism underlying the differential MYF6 expression in 
postnatal skeletal muscle of Duroc and Pietrain breeds (Gene. 486: 8–14, 
2011) 
 16-37 
   
2.2 Chapter 2  
Sulforaphane causes a major epigenetic repression of myostatin in porcine 
satellite cells (Epigenetics: under revision) 
 38-68 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 VI 
List of abbreviations 
 
3'UTR : 3' untranslated region 
5-aza-dC : 5-aza-2′-deoxycytidine 
5'UTR : 5' untranslated region 
18S : 18S ribosomal RNA 
ActRIIB : Activine type II receptor 
ATF : Activating transcription factor  
BS : Binding site 
BSP : Bisulfite sequencing PCR 
CGIs : CpG islands 
ChIP : Chromatin immunoprecipitation 
CREB : cAMP response element binding protein 
Ct : Threshold cycle 
DNMT1 : DNA methyltransferase 1 
DMSO : Dimethyl sulfoxide 
EAAs : Essential amino acids 
EDTA : Ethylenediaminetetraacetic acid 
ELISA :  Enzyme-linked immunosorbent assay 
FBS : Fetal bovine serum 
FIG : Figure 
FoxO1 : Forkhead box O1 
FST : Follistatin 
GAPDH : Glyceraldehyde 3-phosphate dehydrogenase 
GDF8 : Growth differentiation factor 8 
GM : Growth medium 
GREs : Glucocorticoid response elements 
H4K5 : Histone 4 acetylation at lysines 5 
H4K8 : Histone 4 acetylation at lysines 8 
HCl : Hydrogen chloride 
HDAC : Histone deacetylase 
HPRT1 : Hypoxanthine phosphoribosyltransferase 1 
HRP : Horseradish peroxidase 
VII 
hSGT 
: Human small glutamin-rich tetratricopeptide repeat-containing 
protein 
MEF2 : Myocyte enhancer factor 2 
MEMα : Minimum essential medium α 
MHC : Myosin heavy chain 
min : Minutes 
miRNAs : MicroRNAs 
MRF : Myogenic regulatory factor 
MRF4 : Myogenic regulatory factor 4 
mRNA : Messenger RNA 
MSTN : Myostatin 
MYF5 : Myogenic factor 5 
MYF6 : Myogenic factor 6 
MyoD : Myoblast determination protein 
MYOG : Myogenin 
NaCl : Sodium chloride 
ng  : Nanogram 
nM : Nanomol 
NP-40 : Nonidet-P40 
NPDFs : Nasal polyp-derived fibroblasts  
NTC : No template control 
oC : Degree celsius 
PBMC : Peripheral blood mononuclear cells 
PBS : Phosphate-buffered saline 
qPCR : Quantitative polymerase chain reaction 
qRT-PCR : Quantitative real time polymerase chain reaction 
RYR1 : Rryanodine-receptor gene 
S.D. : Standard deviation 
SDS : Sodium dodecyl sulphate 
SDS-PAGE : Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
S.E. : Standard error 
SFN : Sulforaphane 
Smad2 : Smad family member 2 
 VIII 
Smad3 : Smad family member 3 
Smad4 : Smad family member 4 
Smad7 : Smad family member 7 
Smurf1 : Smad specific E3 ubiquitin protein ligase 1 
SRF : Serum response factor 
TFBS : Transcription factor binding site 
TGF-β : Transforming growth factor-β 
TSA : Trichostatin A 
TTBS : Tween-Tris-buffer saline 
µg : Microgram 
µM : Micromol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IX 
 
List of tables 
2.1 Chapter 1  
Table 1:  List of primer sequences 31 
2.2 Chapter 2  
Table 1: 
 
 List of primer sequences used in this study 57 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 X 
List of figures 
2.1 Chapter 1   
Figure 1:  Sequence map of MYF6 including the 13 CpG 
dinucleotides (shaded) and the predicted binding sites of c-
myb (CpG5 and CpG6) and E2F1 (CpG8 and CpG9) 
(encircled) 
 32 
Figure 2:  Determination of MYF6 mRNA and protein levels.  32 
Figure 3:  Determination of c-myb mRNA and protein levels.  33 
Figure 4:  Determination of E2F1 mRNA and protein levels.  33 
Figure 5:  Determination of DNMT1 mRNA and protein levels.  34 
Figure 6:  Cytosine methylation of MYF6 5´-regulatory region.  34 
Supplementary 
Figure 1: 
 
Methylation profile of MYF6 
 35 
Supplementary 
Figure 2: 
 
Determination of global acetyl-Histone H4 (Lys 5, H4K5) 
level. 
 36 
Supplementary 
Figure 3: 
 
Determination of global acetyl-Histone H4 (Lys 8, H4K8) 
level. 
 37 
2.2 Chapter 2   
Figure 1:  Epigenetic reagents affect porcine satellite cell culture and 
inhibit HDAC activity. 
 59 
Figure 2:  FST variants were not involved in epigenetic effects of 
SFN on satellite cell. 
 60 
Figure 3:  MSTN and its signalling pathway were inhibited by SFN 
treatment. 
 61 
Figure 4:  Predicted miRNAs targeting porcine MSTN 3'UTR region 
were not implicated in MSTN epigenetic repression. 
 62 
Figure 5:  MyoD expression and occupancy in the MSTN promoter 
were significantly diminished by SFN and 5-aza-dC. 
 63 
Figure 6:  SFN and 5-aza-dC caused weak enrichment of acetylated 
histones around the MSTN BS1. 
 64 
 
 
 
 
 
 
Overview 1 
1.1 Introduction 
 
Skeletal muscle performance is one of the main economic traits in meat production. Pig 
breeding has focused on selection for improving muscle growth during the past 50 years 
(Merks, 2000). Pig breeds differ for their muscle phenotypes (i.e., myofiber numbers 
and myofiber types). Duroc and Pietrain pig breeds represent two extremes of western 
pig breeds (Cagnazzo et al., 2006). Duroc pigs have slower growing and redder muscle 
fiber types (Sellier, 1998), and Pietrain pigs have faster growing and whiter muscle fiber 
types (Jones, 1998; Sellier, 1998). Pietrain pigs are more muscular than Duroc pigs, 
whereas Duroc pigs are fatter than Pietrain pigs (Cagnazzo et al., 2006). However, the 
mechanism underlying these breed-specific differences of muscle phenotypes is poorly 
known.  
Skeletal muscle develops from mesodermal stem cells by complex consecutive steps 
including mesenchymatous cells determination, progenitor cells proliferation, terminal 
differentiation and myoblasts fusion into myotubes (Joulia-Ekaza and Cabello, 2007; 
Schnorrer and Dickson, 2004). The amount of muscle fibres originating from myoblast 
proliferation and fusion is determined at or close to birth in many vertebrates. Postnatal 
muscle growth relies on the myogenesis of quiescent muscle stem cells — satellite cells 
located along the fibres which give rise to committed myogenic cells (Joulia-Ekaza and 
Cabello, 2007). These latter cells (myoblasts) can proliferate, migrate, differentiate and 
subsequently fuse with the muscle fibres to contribute more myonuclei that sustain 
postnatal muscle repair and growth (Sambasivan and Tajbakhsh, 2007). 
Many genes regulating the well-orchestrated multistep process of myogenesis are 
known. The muscle regulatory factors (MRF) (e.g. myogenic factor 5 (MYF5), 
myoblast determination protein (MyoD), myogenin (MYOG) and myogenic factor 6 
(MYF6)) take central positions in the regulation of myogenesis (Rudnicki and Jaenisch, 
1995). MRFs are expressed in a coordinated and sequential manner when satellite cells 
are activated. The transcription factors MyoD and Myf5 are expressed in proliferating 
undifferentiated myoblasts, whereas MYOG and MYF6 are subsequently expressed at 
the differentiation stage, respectively (Sartorelli and Caretti, 2005; Tapscott, 2005). In 
contrast to other MRFs, MYF6 is the most abundantly expressed myogenic factor in 
adult muscle (Bober et al., 1991; Hinterberger et al., 1991) which is also involved in 
myogenesis, regulation of muscle fiber phenotype and maintainance of the 
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differentiated skeletal phenotype (Simon et al., 1995). MYF6 tends to be expressed 
more highly in muscle tissue of the lean selection line. This could be the result of the 
higher lean mass of Pietrain (te Pas et al., 2000). Accordingly, MYF6 is considered as 
one promising candidate gene for growth- and meat quality-related traits in adult pigs 
(Maak et al., 2006).  
In comparison with MRFs, myostatin (MSTN) has been considered as a potent negative 
regulator of muscle development and growth. Knockout of the MSTN gene resulted in a 
dramatic and widespread increase in mstn−/− mice skeletal muscle mass (McPherron et 
al., 1997). Xu et al. (Xu et al., 2003) report that in zebrafishes, similar as in mice, 
inhibition of MSTN activity induces an increase in muscle growth. In addition, 
inhibition of MSTN by its antibody treatment in mice specifically increases skeletal 
muscle mass without effects on organ size and histology, or various serum parameters 
(Whittemore et al., 2003). Cattle breeds such as Belgian Blue carry natural MSTN gene 
mutations, exhibiting a notably increased muscle mass (Charlier et al., 1995).  
Nowadays, the MSTN pathway is better understood which comprises myoblast 
progression inhibition in the cell cycle, myoblast terminal differentiation inhibition and 
association with protection from apoptosis (Joulia-Ekaza and Cabello, 2006). The active 
dimer of MSTN can bind to the activine type II receptor (ActRIIB) which is capable of 
recruiting and activating the type I receptor (ALK4 or ALK5). Smad family member 2 
and 3 (Smad2 and Smad3) are subsequently activated and form complex with Smad 
family member 4 (Smad4) which are then translocated to the nucleus, regulating target 
gene transcription. Many signalling partners of MSTN have been identified, particularly 
MSTN-binding proteins such as follistatin, human small glutamin-rich tetratricopeptide 
repeat-containing protein (hSGT), Smad family member 7 (Smad7) and Smad specific 
E3 ubiquitin protein ligase 1 (Smurf1). In muscle, these partners interact with MSTN to 
prevent latent complex formation and consequently inhibit MSTN secretion and 
activation (Joulia-Ekaza and Cabello, 2007).  
Evidences have accumulated to support roles for transcription factors in the trans-
regulation of MSTN expression. Many transcription factor binding sites have been 
identified and experimentally confirmed in the MSTN promoter region. The effects of 
MyoD on MSTN promoter have been characterized and it was observed that MyoD can 
interact with the MSTN promoter and enhance its activity to directly up-regulate MSTN 
expression (Salerno et al., 2004; Spiller et al., 2002). Moreover, the glucocorticoid 
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response elements (GREs) were found to be present within the MSTN promoter. Using 
C2C12 myoblasts exposed to dexamethasone, glucocorticoids stimulated both the 
MSTN promoter's transcriptional activity and the endogenous MSTN expression in a 
dose-dependent way (Ma et al., 2001). Another in vivo study also showed that 
intramuscular MSTN mRNA and protein expression were elevated in rats administrated 
with dexamethasone (Ma et al., 2003). Furthermore, FoxO1, a member of the Forkhead 
Box O (FoxO) transcription factor family, could activate MSTN promoter activity to 
inhibit myogenesis through interaction with its binding motifs in the MSTN promoter 
region (Allen and Unterman, 2007).  
More importantly, these regulatory myogenesis-related genes do not act in isolation and 
there are increasing evidences that interactions between epigenetic modulators of 
chromatin, and microRNAs (miRNAs) are all implicated in myogenesis process (Sousa-
Victor et al., 2011). These muscle-specific genes seems to be controlled epigenetically 
during myogenesis. Indeed, the recruitment of satellite cells is achieved by an 
integration of genetic and epigenetic events, ranging from transcription factors, DNA 
methylation, covalent histone modifications and miRNAs which in conjunction 
implement the regulation of muscle-specific genes expression (Palacios and Puri, 2006; 
Sartorelli and Caretti, 2005). In mammals, the cytosine of a CpG dinucleotide can be 
methylated and the methylation of CpG within promoters suppresses genes expression 
(Lande-Diner et al., 2007). Various histone acetylation at a variety of lysine residues 
constitutes the complex histone code (Jenuwein and Allis, 2001). Generally, 
hyperacetylation correlates with gene activation, whereas deacetylation correlates with 
gene silencing (Fry and Peterson, 2001). miRNAs are a population of non-coding small 
RNAs that negatively regulate gene expression at posttranscriptional level. miRNAs can 
silence mRNAs by endonuclease cleavage, translational repression and mRNA 
degradation (Valencia-Sanchez et al., 2006). However, epigenetic studies have  
emerged only during the last years in the skeletal muscle field (Perdiguero et al., 2009; 
Sousa-Victor et al., 2011).  
Previous reports show that demethylation within the distal enhancer of MyoD and 
MYOG promoter appears essential for the differentiation program to proceed (Lucarelli 
et al., 2001; Palacios and Puri, 2006). Recent study demonstrates that MYOG activation 
can be restricted by DNA methylation until other two transcription factors are co-
expressed during embryonic myogenesis and in myoblasts (Palacios et al., 2010). DNA 
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methylation pattern of the 5'-flanking of the MYOG gene with no CpG island and low 
CpG density were examined in both C2C12 muscle satellite cells and embryonic 
muscle. A kinetically controlled equilibrium between CpG and non-CpG demethylation 
regulates MYOG transcriptional activation during muscle differentiation (Fuso et al., 
2010).  
In addition to DNA methylation, histone acetylation is a major source of epigenetic 
information. Epigenetic mechanisms that act on chromatin-related histones are more 
thoroughly delineated. Histone acetylation of various lysine residues of histones H3 and 
H4 represents the permissive mark of gene expression (Sousa-Victor et al., 2011). In 
quiescent and proliferating satellite cells, the promoters of genes involved in myoblasts 
differentiation exhibit hypoacetylated histones which are associated with genes 
repression (Palacios and Puri, 2006; Sartorelli and Caretti, 2005). A recent genome wide 
study revealed that MyoD constitutively binds to thousands of additional sites during 
myogenesis and this genome-wide binding of MyoD was correlated with local histone 
acetylation (Cao et al., 2010). 
Moreover, accumulating evidences describe the post-transcriptional regulatory roles for 
miRNAs during myogenesis. The miRNA molecules typically target the 3' untranslated 
region (UTR) of mRNAs by base pairing, which triggers mRNA decay (if the base 
pairing is perfect) or translational repression (if it is imperfectly matched) (Hutvagner, 
2005; Pattanayak et al., 2005). The “myomiRs” or muscle-specific miRNAs such as 
miR-1 and miR-133 are transcribed together, but manifesting contrasting roles in 
muscle proliferation and differentiation. MiR-1 stimulates myogenesis by targeting 
histone deacetylase 4 (HDAC4) whereas miR-133 promotes myoblasts proliferation by 
suppressing serum response factor (SRF) (Chen et al., 2006). Interestingly, miR-27 is 
expressed in both activated satellite cells of the adult muscle and differentiating skeletal 
muscle in the embryonic myotome. This miR-27 defines normal entry into the 
myogenic differentiation process through specifically targeting Pax3 mRNA (Crist et 
al., 2009). MiR-29 acts as a positive regulator of myogenesis through suppression of the 
YY1 transcription factor which repress muscle-specific gene expression (Wang et al., 
2008).  
More interestingly, several studies have demonstrated miRNAs are implicated in MSTN 
expression. A new target site for miR-1 and miR-206  created by “G” to “A” transition 
in the 3′UTR of MSTN enables MSTN translational inhibition and lead to the muscle 
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hypertrophy in Texel sheep (Clop et al., 2006). Recently, it was confirmed that miR-27b 
efficiently target the 3′UTR of MSTN which may contribute to glucocorticoid-mediated 
MSTN expression in skeletal muscle (Allen and Loh, 2011). Drummond et al. 
(Drummond et al., 2009) show the association of miR-499, -23a, -1, and -206 rapid up-
regulation with human skeletal muscle MSTN down-regulation. The increase of miR-
499 may account for the reduced MSTN expression based on miR-499 efficiently 
targeting the 3′UTR of MSTN experimentally validated (Bell et al., 2010). In defining 
the epigenetic regulation of MSTN expression, other epigenetic elements such as DNA 
methylation and histone acetylation may also participate, but still far from being 
understood. 
Sulforaphane (SFN), an isothiocyanate derived from cruciferous vegetables, is 
identified as antioxidant, anti-carcinogenic and chemotherapeutic agent (Guerrero-
Beltran et al., 2010), but evidence is mounting that SFN also has the ability to inhibit 
type I and II HDAC and functions via epigenetic mechanisms (Dashwood and Ho, 
2007). In human colorectal cancer cells and prostate epithelial cells, concomitant global 
and P21 promoter-specific histone acetylation increase induced by HDAC inhibition 
was associated with elevated expression of P21 protein (Myzak et al., 2006b; Myzak et 
al., 2004). In vivo studies in SFN-fed mice, global and local hyperacetylation was 
accompanied by inhibition of HDAC activity in various tissues (Myzak et al., 2006a). In 
healthy human volunteers, oral consumption of SFN-rich broccoli sprouts led to a 
potent HDAC inhibition associated with elevated histone acetylation at 3 and 6 h in 
peripheral blood mononuclear cells (PBMC) (Dashwood and Ho, 2007; Myzak et al., 
2007). These findings revealed that the chemoprevention mechanism of SFN is via 
epigenetic modifications associated with HDAC activity inhibition.  
In the muscle cell context, there is growing interest in dietary HDAC inhibitors and 
their impact on epigenetic mechanisms affecting muscle cell phenotypes. In comparison 
to SFN, in vitro intervention with another HDAC inhibitor—trichostatin A (TSA) can 
stimulate myoblast recruitment and fusion with an increased cell size (Iezzi et al., 2002; 
Iezzi et al., 2004). An in vivo study demonstrated that intraperitoneal injections of TSA 
increase muscle fiber size in dystrophin-deficient (MDX) mice (36). The dissected 
mechanism underlying HDAC inhibitor-mediated increase of muscle size and satellite 
cell recruitment were via inducing the expression of the natural MSTN antagonist FST 
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(Iezzi et al., 2004; Lee, 2004). However, as the new natural HDAC inhibitor, SFN 
epigenetically regulating FST or MSTN signalling pathway genes is unknown.  
To sum up, we took the following considerations and carried out the in vivo and in vitro 
experiments in this thesis:  
1. Epigenetic studies are emerging only during the last years in the skeletal muscle 
research field. Only recently, epigenetic research has been conducted in association 
with skeletal muscle, thus increasing our interests in the epigenetic mechanisms 
regulating muscle gene expression. 
2. In vivo study: Duroc and Pietrain pigs differ remarkably in their skeletal muscle 
phenotypes. However, the mechanism underlying these breed-specific differences 
of muscle properties is poorly known. The MYF6 gene is predominantly expressed 
in the adult muscle. Up to now, no data are available concerning DNA methylation 
and histone acetylation pattern of MYF6 5′-regulatory region in pigs. Therefore, the 
importance of these epigenetic modifications in the modulation of porcine MYF6 
gene expression was aimed to be explored. The potential roles of these epigenetic 
modifications variations in breed-specific expression of MYF6 in loin eye muscle 
of 6-month female pure breed Pietrain and Duroc pigs was aimed to be evaluated. 
(Chapter 1) 
3. In vitro study: Satellite cells act as the muscle stem cells to support postnatal 
muscle growth. HDAC inhibitor TSA in vivo and in vitro studies revealed its roles 
in promoting myoblast fusion, recruitment of satellite cells and increasing muscle 
fiber size via inducing MSTN antagonist FST. However, epigenetic regulatory 
roles of SFN as a novel natural HDAC inhibitor in muscle cells remain 
undiscovered. Therefore, SFN epigenetically regulating FST or MSTN signalling 
pathway genes was aimed to be examined. (Chapter 2) 
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1.2 Materials and methods 
 
To achieve the objectives of this study, multiple materials and methods were used. The 
details of materials and methods could be found in the respective chapters of this thesis. 
The principle of the main methods and their applications are briefly described here.  
 
1.2.1 Quantitative Real-time PCR (qRT-PCR) 
qRT-PCR is a frequently used new molecular laboratory technique to amplify and 
simultaneously quantify a targeted DNA molecule. The distinct feature is that the 
amplified template can be detected during the reaction progress in real time, whereas 
the conventional PCR detects the product of reaction at its end. The quantity of 
interested molecule can be either an absolute copies number or a relative amount when 
normalized to additional reference genes. In the in vivo study of this thesis, nine-fold 
serial dilution of plasmid DNA were prepared and used as template for the generation of 
the standard curve. qRT-PCR was performed in an ABI prism® 7000 (Applied 
Biosystems) qPCR system. The amount of transcript of target genes present in each 
sample were determined using the Maxima SYBR Green/ROX qPCR Master Mix 
(Fermentas). Each RT-PCR quantification experiment was performed in duplicate for 
individual sample. No template control (NTC) was set to monitor the possible 
contamination of genomic DNA. Melting curves were performed to investigate the 
specificity of the PCR reaction. Final results were reported as the relative expression 
normalized with the transcript level of the endogenous reference TOP2B (Erkens et al., 
2006; Van Poucke et al., 2001) (Chapter 1). In the in vitro study, qRT-PCR was 
performed with a StepOnePlus Real-Time PCR System (Applied Biosystems) using 
miScript SYBR Green PCR Kit (218073, Qiagen) and iTaq SYBR Green Supermix 
with ROX (172-5850, Bio-Rad) for the detection of miRNAs and mRNAs, respectively. 
qRT-PCR data were analysed using the 2-∆∆Ct method (Livak and Schmittgen, 2001) 
with hypoxanthine phosphoribosyltransferase 1 (HPRT1) (Uddin et al., 2011) for 
mRNAs and 18S ribosomal RNA for miRNAs as endogenous references (Chapter 2). 
 
1.2.2 Western blotting analysis  
Western blot is a widely used molecular approach to determine specific interested 
proteins in the cell or tissue extract. After gel electrophoresis, the proteins are then 
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transferred to a membrane (nitrocellulose or PVDF), where they are probed with 
antibody against the target protein. Finally, the membrane was washed and the specific 
signals were detected by chemiluminescence. In the in vivo study of this thesis, 
enhanced chemiluminescence signals recorded on X-ray film were scanned and 
visualized by Kodak BioMax XAR film (Kodak). Results were shown as the relative 
band intensities normalized to the area densities of GAPDH bands for each lane using 
Image-J software (National Institute of Mental Health, Bethesda, Maryland, USA) 
(Chapter 1). In the in vitro study, the specific signals were detected by 
chemiluminescence using the SuperSignal West Pico Chemiluminescent Substrate 
(34077, Thermo Scientific). Images were acquired by Quantity One 1-D analysis 
software (Bio-Rad) (Chapter 2). The detailed procedure and specific antibodies can be 
found in the respective chapters. 
 
1.2.3 Bisulfite sequencing PCR 
Bisulfite sequencing PCR is a precise and widely used epigenetic method to determine 
DNA methylation pattern of interested gene. Bisulfite treatment of genomic DNA 
converts cytosine residues to uracil, but keeps 5-methylcytosine residues unconverted. 
Hence, bisulfite treatment induces specific changes in the DNA sequence which are 
based on the methylation status of individual cytosine residues. In this thesis, genomic 
DNA was subjected to bisulfite modification using EZ DNA Methylation Kit (Zymo 
Research). The bisulfite PCR products were purified with QIAquick PCR purification 
kit (Qiagen) and then subcloned into the pGEM T-easy vector (Promega). Different 
positive clones for each subject were randomly selected for sequencing with M13 
primers performed by the CEQ8000 sequencer system (Beckman Coulter). The final 
sequence results were processed by QUMA (Kumaki et al., 2008) software. Sequences 
with a conversion rate below 90% were excluded from analysis. 
 
1.2.4 Chromatin immunoprecipitation (ChIP)  
ChIP is a type of immunoprecipitation experimental technique used to evaluate DNA 
and protein interaction. It aims to determine the association of specific proteins with 
specific genomic regulatory regions, such as transcription factor binding sites on 
promoters. ChIP is also able to determine the specific histone modifications in the 
genome. In short, the method is as follows: chromatin and proteins are temporarily 
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cross-linked, the chromatin-protein complexes are then sheared and DNA fragments 
interacting with the interested proteins are selectively immunoprecipitated, and the 
related DNA are isolated and purified which are subject to ChIP quantitative PCR 
(ChIP-qPCR). These DNA sequences are supposed to interact with the protein of 
interest in vivo. In this thesis, the chromatin immunoprecipitation (ChIP) assay kit (17-
295, Millipore) was used. Antibodies against RNA polymerase II (sc-899 X, Santa 
Cruz) and normal rabbit IgG (2729S, Cell signaling Technology) were used as a 
positive and a negative control in the assay, respectively. PCR products were separated 
on 2% agarose gel stained with ethidium bromide for visualization. QPCR data were 
normalized to and expressed as % of input (Chapter 2).  
 
1.2.5 Statistical analysis 
Results from qRT-PCR and Western blotting analysis were expressed as mean ± SEM. 
The difference between values was analyzed by t-Test in SAS software v.9.2 and P < 
.05 was set statistically significant (Chapter 1). Pairwise comparisons were made 
between treatment groups and the vehicle-treated control, using Student’s t test. The 
data were expressed as means ± standard deviations (SD) and (*) P < .05, (**) P <.01, 
(***) P <.001 were set statistically significant (Chapter 2).   
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1.3 Results 
 
The main results in this thesis are briefly described here. The detailed description of the 
results can be found in the respective chapters.  
 
1.3.1 MYF6 expression was trans-activated and up-regulated by enriched transcription 
factor E2F1 in Pietrain breed  
In the chapter 1, in order to evaluate the potential roles of epigenetic modifications 
variations in breed-specific expression of MYF6, six months old female Duroc and 
Pietrain pure breed pigs were used. qRT-PCR and Western blotting results revealed that 
mRNA and protein expression of MYF6 were dramatically higher in Pietrain pigs 
compared to Duroc pigs and suggested breed-specific expression. Variations in DNA 
methylation of the MYF6 gene 5´-regulatory region, particularly within important 
transcription factor binding elements, are shown to occur between breeds. Furthermore, 
DNMT1 exhibited higher levels in both mRNA and protein expression in Pietrain pigs, 
indicating global hypermethylation status in Pietrain pigs. The histone acetylation levels 
at both H4K5 and H4K8 sites were not different between two breed pigs. However, in 
Pietrains pigs, higher expression of MYF6 is not consistent with hypermethylation 
status, but concurrent with enriched E2F1 expression.  
 
1.3.2 Sulforaphane epigenetically represses MSTN expression in porcine satellite cell  
In the chapter 2, in order to assess epigenetic effects of SFN supplementation on 
satellite cell, satellite cells were isolated from the right and left semimembranosus 
muscles of 20 days old purebred Pietrain piglets. Apart from SFN, we also employed 
the typical epigenetic reagents 5-aza-2′-deoxycytidine (5-aza-dC) and TSA. 
Distinguished from TSA, SFN and 5-aza-dC remarkably suppress MSTN expression and 
inhibit HDAC activity as well as DNA methyltransferase (DNMT) expression. 
Significantly reduced MyoD enrichment associated with hypoacetylation of the MyoD-
binding site in the MSTN promoter were observed simultaneously in SFN and 5-aza-dC 
groups.  
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1.4 Conclusions  
 
In this thesis, we conducted in vivo study in skeletal muscle and in vitro study in 
satellite cells with the aims to understand the epigenetic and molecular mechanisms 
regulating muscle gene expression. 
In the in vivo study, we selected MYF6 as one of the contributing factors to the 
postnatal breed-specific muscle properties in two breed pigs. The increased MYF6 
transcription in postnatal porcine skeletal muscle is not coordinated with cis-activation 
by epigenetic modifications of MYF6 5´-regulatory region, but may be attributed to 
trans-activation through enriched E2F1 expression. In addition to its practical 
implications, this work extends our understanding the role of epigenetic mechanism in 
postnatal pigs. In comparison with epigenetic modifications during the embryonic stage, 
DNA methylation variations of MYF6 in adult pigs may be attributed to the 
environmental factors (Aguilera et al., 2010), as well as the selection pressure. In 
conclusion, our findings provide the first evidence that postnatal MYF6 expression and 
DNA methylation variations within 5´-regulatory region occur differentially between 
breeds and may lead to novel insights and clues into the selection of lean-type pigs. 
However, further experiments are required to fully clarify the exact signalling pathway 
for MYF6 transcriptional activation by enriched E2F1.  
In the in vitro study, we found that both 5-aza-dC and SFN dramatically inhibit HDAC 
activity and DNMT1 expression. SFN, 5-aza-dC and TSA exhibited differential 
mechanisms to repress MSTN expression and negative regulators of MSTN pathway. 
Previous studies has shown protective effects of SFN treatment on rat skeletal muscle 
damage and oxidative stress (Malaguti et al., 2009), but not in the context of 
epigenetics, and to our knowledge this is the first study with SFN in satellite cells. 
Deregulated miRNA may be excluded from epigenetic repression of MSTN. However, 
epigenetic suppression of MSTN by 5-aza-dC and SFN is associated with the decreased 
MyoD expression, reduced binding of MyoD on MSTN promoter and hypoacetylation in 
MyoD binding site. These observations manifest a novel mechanism for manipulation 
of muscle cell phenotypes.  
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Abstract 
Among modern western pigs, Duroc (high meat fat ratio) and Pietrain (low meat fat 
ratio) breeds extensively utilized in commercial pork production differ extremely for 
their muscle phenotypes. The molecular mechanism, especially the epigenetic 
mechanism, underlying these breed-specific differences is poorly known. Myogenic 
factor 6 (MYF6) is the most abundantly expressed myogenic factor in adult muscle. 
Moreover, MYF6 tends to be expressed more highly in muscle tissue of the lean 
selection line and is supposed to be one promising candidate gene for growth- and meat 
quality-related traits in adult pigs. Six months old female Duroc and Pietrain pure breed 
pigs were used in this study. Protein and mRNA levels of MYF6 in loin eye muscle 
were determined by Western blotting and quantitative Real-time reverse transcription 
PCR (qRT-PCR), respectively. The DNA methylation status of the MYF6 5´-regulatory 
region was determined by bisulfite sequencing PCR (BSP). The global Histone 4 
acetylation at lysines 5 (H4K5) and 8 (H4K8) were examined by Western blotting. 
Pietrain pigs exhibited significant higher expression of MYF6 and hypermethylated 
E2F1 binding element within MYF6 5´-regulatory region as compared with Duroc pigs. 
Significant elevation in DNA methyltransferase 1 (DNMT1) expression was observed 
in Pietrain pigs which is in agreement with hypermethylation of MYF6. Histone 
acetylation level at neither H4K5 nor H4K8 is significant between two breed pigs. 
Nevertheless, mRNA and protein expression of E2F1 were significantly elevated in the 
Pietrain breed. It is thus conceivable that the upregulation of MYF6 transcription in 
postnatal Pietrain pigs is not associated with cis-activation by epigenetic modification of 
MYF6 5´-regulatory region, but may be attributed to trans-activation through enriched 
expression of E2F1. 
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1. Introduction 
Commercial western pig breeds have been selected for meat production over the past 50 
years. Pietrain (low meat fat ratio) and Duroc (high meat fat ratio) pig breeds are two 
extremes in skeletal muscle phenotypes (Cagnazzo, te Pas et al. 2006). The myogenic 
factor 6 (MYF6/myogenic regulatory factor 4, MRF4) gene codes for the bHLH 
transcription factor belonging to MyoD family. The expressed MYF6 is involved in the 
processes of differentiation and maturation of myotubes during embryogenesis and 
dominates quantitatively over the other MRFs in adult muscle (Bober, Lyons et al. 
1991; Hinterberger, Sassoon et al. 1991; Wyszynska-Koko and Kuryl 2004). Increases 
in MYF6 mRNA and protein may play a role in the differentiation of adult fibers 
(Lowe, Lund et al. 1998). MYF6 is also involved in regulation of muscle fiber 
phenotype and maintainance of the differentiated skeletal phenotype (Miner and Wold 
1990; Walters, Stickland et al. 2000). Interestingly, MYF6 tends to be expressed more 
highly in muscle tissue of the lean selection line which has higher lean mass and 
expression of MYF6 in the thicker muscle fibers for maintenance (te Pas, Verburg et al. 
2000). Therefore, MYF6 is supposed to be one promising candidate gene for growth- 
and meat quality-related traits in adult pigs (Maak, Neumann et al. 2006).  
Numerous studies in the past decade have unveiled that epigenetic control of chromatin 
structure is essential for eukaryotic gene activation and inactivation. This epigenetic 
regulation is mainly performed by DNA methylation and histone modification 
(Matsubara, Takahashi et al. 2010). The DNA methylation and histone modification are 
functionally linked with each other to regulate gene expression (Cedar and Bergman 
2009; Matsubara, Takahashi et al. 2010). Generally, in mammals the cytosine of a CpG 
dinucleotide can be methylated. Gene which is hypermethylated is silenced and one 
gene which is hypomethylated is actively transcribed. A variety of histone acetylation at 
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various lysine residues constitutes the complex histone code (Jenuwein and Allis 2001). 
In general, acetylation of histone 4 correlates with gene activation, while deacetylation 
correlates with gene silencing (Fry and Peterson 2001). In the skeletal muscle field, 
epigenetic studies have really emerged only during these last years, thereby increasing 
our understanding of the mechanisms regulating muscle gene expression (Perdiguero, 
Sousa-Victor et al. 2009). It was reported that demethylation including the distal 
enhancer of Myod and Myog promoter appears necessary for the differentiation program 
to proceed (Lucarelli, Fuso et al. 2001; Palacios and Puri 2006). However, the precise 
mechanisms regulating methylation/demethylation during adult myogenesis are still far 
from being understood (Perdiguero, Sousa-Victor et al. 2009). 
Duroc and Pietrain pigs differ considerably in their skeletal muscle properties. In 
addition, the MYF6 gene is quantitatively dominant over the other MRFs in the adult 
muscle. Up to now, no data are available concerning methylation and histone 
acetylation status of MYF6 5´-regulatory region in pigs. The present study was aimed to 
answer the following questions. First, would  predominantly expressed MYF6 in the 
adult muscle be differentially expressed in Duroc and  Pietrain breeds? Second, was 
such differential expression, if any, epigenetically regulated? Third, did epigenetic 
control involve transcription factors interaction with their target DNA? To address these 
issues, we first characterized the sequence of MYF6 and observed its mRNA and protein 
expression using quantitative Real-time reverse transcription PCR (qRT-PCR) and 
Western blotting. Bisulfite sequencing PCR (BSP) was performed to quantify DNA 
methylation status within two putative transcription factor elements. Furthermore, we 
investigated the global Histone 4 acetylation at lysines 5 (H4K5) and 8 (H4K8) level 
using Western blotting. Eventually, we examined E2F1 mRNA and protein expression 
using qRT-PCR and Western blotting, suggesting a trans-regulating mechanism in 
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postnatal porcine skeletal muscle MYF6 activation.  
2. Materials and methods 
2.1. Experimental animals and samples 
Six pure breed Pietrain and four pure breed Duroc female pigs at the age of 6-month 
were used in this study. All the pigs were kept and slaughtered at a commercial abattoir 
according to German performance test directions (ZDS, 2004). The loin eye muscle of 
each pig was dissected and immediately frozen in liquid nitrogen within 5 min after 
slaughter. Then the samples were stored at –80°C until DNA, RNA and protein 
isolation.  
2.2. In silico analysis of MYF6  
The 5´-regulatory region of the published sequence (GenBank ID: AY327443) which 
contains the promoter and 5´-untranslated region (5´-UTR) of MYF6 gene was 
submitted to the online program: Methprimer (Li and Dahiya 2002) to identify the CpG 
islands (CGIs). The 5´-regulatory region was screened and analyzed for cis-acting 
elements involved in trans-activation within the CpG island using TFSEARCH 
(http://www.cbrc.jp/research/db/TFSEARCH.html). The cis-acting elements prediction 
results were confirmed by TESS (http://www.cbil.upenn.edu/cgi-bin/tess/tess). 
2.3. Isolation of mRNA, protein and DNA from loin eye muscle 
Total RNA was extracted using TRI reagent (Sigma). RNA was purified using RNeasy 
Mini Kit (Qiagen) according to the manufacturer's instructions. Total RNA was then 
treated using on-column RNase-Free DNase set (Promega) and the concentration was 
quantified by spectrophotometer (NanoDrop, ND8000). RNA quality was checked by 
2% agarose gel electrophoresis. First-strand cDNA was synthesized using Superscript II 
enzyme (Invitrogen). Genomic DNA was isolated by conventional proteinase K 
digestion and phenol-chloroform extraction. The DNA concentration was measured by 
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spectrophotometer (NanoDrop, ND8000). The whole cell protein was extracted using 
Nonidet-P40 (NP-40) buffer (20 mM Tris HCl pH 8, 137 mM NaCl, 10% glycerol, 1% 
IGEPAL CA-630, 2 mM EDTA, 1 mM dithiothreitol). The protein concentration was 
quantified using coomassie (Bradford) protein assay kit (Thermo Fisher Scientific) in 
spectrophotometer (NanoDrop, ND8000) according to the manufacturer's instructions. 
All the mRNA, protein and DNA were stored at –80°C until assay. 
2.4. Quantitative Real-time RT-PCR  
Primers were designed using the online Primer3 program (Rozen and Skaletsky 2000) 
and are listed in Table 1. Nine-fold serial dilution of plasmid DNA were prepared and 
used as template for the generation of the standard curve. Real-time qRT-PCR was 
performed in an ABI prism® 7000 (Applied Biosystems) qPCR system. The amount of 
transcript of target genes present in each sample were determined using the Maxima 
SYBR Green/ROX qPCR Master Mix (Fermentas). Each RT-PCR quantification 
experiment was performed in duplicate for individual sample. Amplification conditions 
were as follows: 10 min at 95°C, 45 cycles of 15 s at 95°C and 1 min at indicated Tm 
listed in Table 1. No template control (NTC) was set to monitor the possible 
contamination of genomic DNA. Melting curves were performed to investigate the 
specificity of the PCR reaction. Final results were reported as the relative expression 
normalized with the transcript level of the endogenous reference TOP2B (Erkens, Van 
Poucke et al. 2006; Van Poucke, Yerle et al. 2001).  
2.5. Western blotting analysis  
Forty micrograms of protein extract were diluted 4:1 with 5 × loading buffer (10% 
glycerol, 2% sodium dodecyl sulphate [SDS], 5% 2-mercaptoethanol, 1% bromophenol 
blue) and denatured by boiling for 5 min before loading on a 12% SDS-PAGE gel. 
After electrophoresis, proteins were transferred to nitrocellulose membranes (Protran®, 
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Schleicher & Schuell Bioscience) and the latter were then blocked with Roti-block 
solution (Carl Roth GmbH) for 1 h at room temperature. After repeated washing with 
Tween-Tris-buffer saline (TTBS), the membranes were incubated with primary 
antibodies specific for MYF6 (rabbit, 1:100; Catalog No. sc-301, Santa Cruz), DNMT1 
(mouse, 1 µg/ml; Catalog No. IMG-261A, Imgenex), E2F1 (mouse, 1:200; Catalog No. 
sc-56662, Santa Cruz), c-myb (rabbit, 1:100; Catalog No. sc-517, Santa Cruz), Acetyl-
Histone H4 Antibody Set (acetyl K5 + K8) (rabbit, 1:500; Catalog No. 17-211, 
Millipore), and GAPDH (goat, 1:3000; Catalog No. sc-20357, Abcam) respectively. 
The membranes were then incubated with horseradish peroxidase (HRP)-conjugated 
secondary antibodies (goat anti-rabbit for MYF6, c-myb and Acetyl-Histone 4, 1:2000, 
Catalog No. sc-2004, Santa Cruz; goat anti-mouse for DNMT1 and E2F1, 1:3000, 
Catalog No. sc-2024, Santa Cruz; donkey anti-goat for GAPDH, 1:5000, Catalog No. 
sc-2020, Santa Cruz). Finally, the membrane was washed and the specific signals were 
detected by chemiluminescence using the ECL plus Western blotting detection system 
(Amersham Biosciences). Enhanced chemiluminescence signals recorded on X-ray film 
were scanned and visualized by Kodak BioMax XAR film (Kodak). Results were 
shown as the relative band intensities normalized to the area densities of GAPDH bands 
for each lane using Image-J software (National Institute of Mental Health, Bethesda, 
Maryland, USA). Relative means were compared between Duroc and Pietrain pigs.  
2.6. Bisulfite sequencing PCR 
Genomic DNA (1 µg) isolated from loin eye muscle was subjected to bisulfite 
modification using EZ DNA Methylation Kit (Zymo Research) according to the 
manufacturer’s protocol. The MYF6  5´-regulatory region was PCR amplified with 
MYF6-met primer pairs (Table 1) designed using the MethPrimer program (Li and 
Dahiya 2002). PCR products were purified with QIAquick PCR purification kit 
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(Qiagen) and then subcloned into the pGEM T-easy vector (Promega). A minimum of 
four different positive clones for each subject were randomly selected for sequencing 
with M13 primers performed by the CEQ8000 sequencer system (Beckman Coulter). 
The final sequence results were processed by QUMA (Kumaki, Oda et al. 2008) 
software. Sequences with a conversion rate below 90% were excluded from analysis. 
2.7. Data analysis 
Results from Real-time qRT-PCR and Western blotting analysis were expressed as 
mean ± SEM. The difference between values was analyzed by T-Test in SAS software 
v.9.2 and P < 0.05 was set statistically significant. 
3. Results  
3.1. In silico analysis of MYF6  
The 5´-regulatory region of MYF6 which contains the promoter and 5´-UTR was 
submitted to online program: Methprimer and two potential CGIs were predicted. 
Thirteen CpG sites were mapped and two putative transcription factor binding sites 
(TFBS for c-myb and E2F1) were found in the MYF6 5´-regulatory region within the 
CpG island. We found 2 CpG sites located in the putative TFBS for c-myb (CpG5 and 
CpG6) and 2 within putative TFBS for E2F1 (CpG8 and CpG9) (Figure 1).  
3.2. Expression of MYF6, c-myb, E2F1 and DNMT1 in the skeletal muscle 
The Real-time qRT-PCR results showed that expression of MYF6, c-myb and E2F1 
gene were markedly higher in Pietrain pigs compared to Duroc pigs (Figure 2a, 3a and 
4a). At protein level, results are in line with the mRNA level except for c-myb that was 
not significantly different at protein level (Figure 2b, 2c; Figure 3b, 3c; Figure 4b, 4c;). 
We also evaluated DNMT1 expression which was higher in mRNA and protein levels in 
Pietrain pigs (Figure 5).  
3.3. DNA methylation profile of MYF6 
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The methylation status of the computationally predicted CpG island in two breeds were 
shown in Supplementary Figure 1. The bisulfite sequencing analysis revealed that the 
average methylation percentage was not different between Pietrain and Duroc pigs (data 
not shown). However, the methylation percentages of 3 CpG sites (CpG7, CpG12 and 
CpG13) were higher in Pietrain pigs than in Duroc pigs (Figure 6a). Moreover, the 
methylation percentages of 2 specific CpG sites within TFBS: CpG5 (Figure 6b) and 
CpG8 (Figure 6c) were significantly higher in Pietrain pigs than in Duroc pigs.  
3.4. Global histone acetylation in the skeletal muscle 
Our results demonstrated that histone acetylation levels at both H4K5 and H4K8 were 
not significantly different between two breed pigs (Supplementary Figure 2 and 3).  
4. Discussion 
The commercial Duroc and Pietrain breeds differ extremely for their muscle phenotypes 
(i.e., myofiber numbers and myofiber types) (Cagnazzo, te Pas et al. 2006). MYF6 is 
the most abundantly expressed myogenic factor in postnatal muscle where it 
quantitatively predominates over the other MyoD family transcripts (Miner and Wold 
1990). Up to now, the importance of epigenetic marks in the regulation of porcine 
MYF6 gene expression is far less explored. In the present study, our Real-time qRT-
PCR and Western blotting results demonstrated that mRNA and protein expression of 
MYF6 were markedly higher in Pietrain pigs compared to Duroc pigs and indicated 
breed-specific expression. Variations in methylation status of the MYF6 gene 5´-
regulatory region, especially within specific transcription factor binding sites, are shown 
to occur between breeds. Additionally, DNMT1 exhibited higher levels in both mRNA 
and protein levels in Pietrain pigs, suggesting hypermethylation status in the loin eye 
muscle of Pietrain pigs. The histone acetylation levels at both H4K5 and H4K8 sites 
were not significantly different between two breed pigs. However, in the loin eye 
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muscle of Pietrains pigs, higher expression of MYF6 is not consistent with 
hypermethylation status, but concurrent with elevated E2F1 expression. We propose 
that the upregulation of MYF6 transcription in Pietrain pigs is not associated with cis-
activation by DNA methylation and histone acetylation in MYF6 5´-regulatory region, 
but may be attributed to trans-activation through enriched expression of transcription 
factor E2F1. 
MYF6 is considered as one promising candidate gene for growth- and meat quality-
related traits in adult pigs (Maak, Neumann et al. 2006). In our studies, the dramatic 
differences both in MYF6 mRNA and protein expression were observed in the 6-month-
old Duroc and Pietrain pigs, suggesting differential expression in breed-specific skeletal 
muscle. It has been shown that increased  MYF6 mRNA  and protein were correlated  
with  increased myofiber size (Bodine and Pierotti 1996) and increased mean fiber area 
(Hespel, Op't Eijnde et al. 2001). In addition, the elevations in MYF6 expression could 
have also facilitated an enhanced transcription of Type I, IIa, and IIx Myosin heavy 
chain (MHC) mRNA molecules. These alterations dependent on the myogenic 
regulation of MYF6 result in hypertrophy in muscle (Willoughby and Rosene 2001; 
Willoughby and Rosene 2003). Therefore, elevated MYF6 may elucidate the fast 
growing fiber types and more muscular property in Pietrain pigs. In line with our 
results, MYF6 tends to be expressed more highly in muscle tissue of the lean-type breed 
(te Pas, Verburg et al. 2000). Considering MYF6 expression is dominant in postnatal 
mature muscle fibers (Olson 1990; Weintraub, Davis et al. 1991), faster growing 
muscles may be more mature at slaughter than slower-growing muscles (te Pas, Verburg 
et al. 2000). Thus, faster-growing muscles in Pietrain pigs show higher MYF6 
expression. The increases in MYF6 mRNA and protein expression in Pietrain may 
provide a possible mechanism for the increase in myofiber size and the change in 
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myofiber types compared to Duroc pigs. 
Epigenetic control of chromatin structure is mainly performed by DNA methylation and 
histone modification (Caiafa and Zampieri 2005). CGIs occur primarily—although not 
exclusively—at the 5´ end of genes, particularly promoters and first exon (Butcher and 
Beck 2008). In our computational analysis, thirteen CpG sites were mapped in one 
plotted CGI in the MYF6 5´-regulatory region. The MYF6 5´-regulatory region contains 
a c-myb and an E2F1 binding site that may serve as the molecular targets. Our bisulfite 
sequencing analysis revealed that the average methylation percentage was not different 
between Pietrain and Duroc pigs. However, variations in methylation status of the 
MYF6 gene 5´-regulatory region, especially within the two putative transcriptional 
factor c-myb and E2F1 binding sites in Pietrain pigs, are shown to occur between 
breeds. These hypermethylated transcripton factor binding elements in the MYF6 gene 
5´-regulatory region of Pietrain pigs, which is in parallel with increased DNMT1 
mRNA and protein expression levels, might be associated with breed-specific 
transcriptional activity and gene expression. Nevertheless, expression level of MYF6 is 
not inversely correlated with DNA methylation status. It was reported that a third of the 
genes analyzed show inverse correlation between the state of DNA methylation in the 
5´-regulatory regions and gene expression, whereas the methylation state did not 
correlate with mRNA expression levels for 63% of the genes (Eckhardt, Lewin et al. 
2006). Corresponding to the latter, our observations suggest that DNA methylation in 
the MYF6 gene 5´-regulatory region might not correlate with MYF6 gene expression.  
Additional factors that could regulate transcription, such as histone modifications or 
transcription factors, should not be neglected. Histone 4 acetylation at lysines 5 and 8 is 
associated with open chromatin leading to gene activation (Hublitz, Albert et al. 2009). 
Our results exibited that global histone acetylation levels at both H4K5 and H4K8 were 
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not significantly different between two breed pigs. Histone acetylation may also not 
play a vital role in MYF6 gene expression. As for trans-regulation, transcription factors 
could exert their transcriptional regulatory effects directly on the gene by specific 
protein–DNA interaction and elicit trans-activation of promoter activity (Weaver, 
D'Alessio et al. 2007). Indeed, we observed a significant difference in c-myb mRNA 
expression and a tendency in protein expression between two breeds. However, because 
of the similar c-myb protein levels for protein-DNA interaction, c-myb may not be 
involved in the enhanced MYF6 expression in Pietrain pigs. Furthermore, mRNA and 
protein levels of another transcription factor E2F1 were both significantly higher 
expressed in Pietrain pigs as opposed to Duroc pigs, indicating a trans-activation of 
skeletal muscle MYF6 transcription in Pietrain pigs. A previous study showed that 
E2F1, which is included in the E1A promoter bind nuclear protein complexes, mediates 
E1A transcriptional (auto)activation (Kirch, Putzer et al. 1993). Accordingly, 
resembling other protein-DNA interaction (Bernard, Quatannens et al. 2001; Moore, 
Narayanan et al. 2007), upon facilitation of more abundant transcription factor 
occurring in its binding element, E2F1 can stimulate MYF6 transcriptional activity in 
Pietrain pigs. What is more, E2F1 is required for adult skeletal muscle regeneration in 
vivo (Yan, Choi et al. 2003) which, to some extent, can account for elevated E2F1 
expression in more muscular adult Pietrain pigs. It is thus conceivable that 
hypermethylation of the MYF6 promoter does not underlie its overexpression in Pietrain 
pigs and E2F1 could regulate MYF6 expression in trans-activating the MYF6 promoter 
containing E2F1 binding site.  
In this study, we suggest that MYF6 might be one of the contributing factors to the adult 
breed-specific muscle properties in two breed pigs. The upregulation of MYF6 
transcription in postnatal porcine skeletal muscle is not associated with cis-activation by 
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epigenetic modification of MYF6 5´-regulatory region, but may be attributed to trans-
activation via enriched expression of E2F1. In addition to its practical implications, this 
work extends our understanding the role of epigenetic mechanism in postnatal pigs. In 
contrast to epigenetic modifications during the embryo stage, DNA methylation 
variations of MYF6 in adult pigs may be attributed to the environmental factors 
(Aguilera, Fernandez et al. 2010), as well as the selection pressure. Taken together, our 
findings provide the first evidence that postnatal MYF6 expression and DNA 
methylation variations within 5´-regulatory region occur differentially between breeds 
and may lead to novel insights and clues into the selection of lean-type pigs. However, 
further experiments are required to fully clarify the exact signalling pathway for MYF6 
transcriptional activation by enriched E2F1.  
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Table 1. List of primer sequences 
Gene 
name 
Primers sequence Tm  
Product 
Size 
GenBank ID 
MYF6 F: TGGATCAGCAGGACAAAATG 
R: TGTTTGTCCCTCCTTCCTTG 
55°C 171 bp AY188502 
DNMT1 F: GCGGGACCTACCAAACAT 
R: TTCCACGCAGGAGCAGAC 
55°C 133 bp DQ060156 
E2F1 F: AGTGGCTAGGCAGCCATGCAG 
R: GCAGGGTCCGCGATGCTACG 
60°C 208 bp XM_001926880 
c-myb F: GTCCGAAACGTTGGTCTGTT 
R: GGCAGTAGCTTTGCGATTTC 
57°C 190 bp XM_001928926 
TOP2B  F: AACTGGATGATGCTAATGATGCT 
R: TGGAAAAACTCCGTATCTGTCTC 
55°C 137 bp AF222921  
MYF6-
met 
F: TTTTTTTGTTAGGATTAAATGTTTT 
R: CTTTAATTAAAATTAACCACAATCC 
57°C 257 bp AY327443 
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Figure 1. Sequence map of MYF6 including the 13 CpG dinucleotides (shaded) and the 
predicted binding sites of c-myb (CpG5 and CpG6) and E2F1 (CpG8 and CpG9) 
(encircled) 
 
 
Figure 2. Determination of MYF6 mRNA and protein levels. (a) mRNA expression in 
Duroc and Pietrain. (b) Representative blots of MYF6 and GAPDH protein. (c) Ratio of 
relative protein levels of MYF6 expressed to GAPDH. (* P < 0.05) 
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Figure 3. Determination of c-myb mRNA and protein levels. (a) mRNA expression in 
Duroc and Pietrain. (b) Representative blots of c-myb and GAPDH protein. (c) Ratio of 
relative protein levels of c-myb expressed to GAPDH. (*P < 0.05) 
 
 
Figure 4. Determination of E2F1 mRNA and protein levels. (a) mRNA expression in 
Duroc and Pietrain. (b) Representative blots of E2F1 and GAPDH protein. (c) Ratio of 
relative protein levels of E2F1 expressed to GAPDH. (*P < 0.05) 
Chapter 1 
 
 
34 
 
Figure 5. Determination of DNMT1 mRNA and protein levels. (a) mRNA expression in 
Duroc and Pietrain. (b) Representative blots of DNMT1 and GAPDH protein. (c) Ratio 
of relative protein levels of DNMT1 expressed to GAPDH. (*P < 0.05) 
 
 
Figure 6. Cytosine methylation of MYF6 5´-regulatory region. (a) Percentage of 
methylated cytosines (mean ± S.E.) for the different CpG dinucleotides. (b) Percentage 
of methylated cytosines (mean ± S.E.) for the site 5 and site 6 CpG dinucleotides within 
the c-myb binding sequence. (c) Percentage of methylated cytosines (mean ± S.E.) for 
the site 8 and site 9 CpG dinucleotides within the E2F1 binding sequence. (*P < 0.05)  
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Duroc (24 colonies) Pietrain (37 colonies) 
 
 
Supplementary Figure 1. Methylation profile of MYF6 (Web-based tool, “QUMA”, 
http://quma.cdb.riken.jp/). Filled (black) circles correspond to methylated Cs, unfilled 
(white) circles correspond to unmethylated Cs. Every row indicates a single colony 
sequence. Every column indicates a single CpG site. Four to five positive colonies were 
picked for each pig.   
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Supplementary Figure 2. Determination of global acetyl-Histone H4 (Lys 5, H4K5) 
level. (a) Representative blots of H4K5 and GAPDH protein. (c) Ratio of relative 
protein levels of H4K5 expressed to GAPDH. (*P < 0.05) 
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Supplementary Figure 3. Determination of global acetyl-Histone H4 (Lys 8, H4K8) 
level. (a) Representative blots of H4K8 and GAPDH protein. (c) Ratio of relative 
protein levels of H4K8 expressed to GAPDH. (*P < 0.05) 
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serum; FST, follistatin; FoxO1, forkhead box O1; GAPDH, glyceraldehyde 3-phosphate 
dehydrogenase GDF8, growth differentiation factor 8; GM, growth medium; HDAC, 
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family member 7; Smurf1, Smad specific E3 ubiquitin protein ligase 1; Ct, threshold 
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Abstract 
Satellite cells function as skeletal muscle stem cells to support postnatal muscle growth 
and regeneration following injury or disease. There is great promise for improvement of 
muscle performance in livestock and therapy of muscle pathologies in human targeting 
myostatin (MSTN) with this cell population. Human diet contains many histone 
deacetylase (HDAC) inhibitors such as the bioactive component sulforaphane (SFN) 
and epigenetic effects of SFN on MSTN gene in satellite cells are unknown. Therefore, 
we aimed to investigate the epigenetic influences of SFN on the MSTN gene in satellite 
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cells. The present work provides the first evidence, distinct from effects of trichostatin 
A (TSA), that SFN supplementation in vitro indeed not only acts as HDAC inhibitor but 
also DNA methyltransferase (DNMT) inhibitor in porcine satellite cells. Compared to 
TSA and 5-aza-2′-deoxycytidine (5-aza-dC), SFN treatment significantly represses 
MSTN expression, accompanied by strongly attenuated expression of negative feedback 
inhibitors of MSTN signalling pathway. miRNAs targeting MSTN are not implicated in 
post-transcriptional regulation of MSTN. Nevertheless, weakly enriched myoblast 
determination protein (MyoD) associated with diminished histone acetylation in MyoD 
binding site located in MSTN promoter region by SFN may contribute to transcriptional 
repression of MSTN. These findings reveal a new mode of epigenetic repression of 
MSTN by the bioactive compound SFN. Given this new pharmacological, biological 
activity of SFN in satellite cells, it may thus allow for developing novel approaches to 
weaken the MSTN signalling pathway both for therapies of human skeletal muscle 
disorders and livestock production. 
Introduction 
Pig is an economically important animal in livestock production, as well as in 
biomedical studies for humans because of the similarity in physiology, organ 
development and disease progression.1 Skeletal muscle growth is one of the major 
economic traits in meat production. Postnatal muscle maintenance and growth rely on 
activation of a unique population of quiescent 'satellite cells' (referred as muscle stem 
cells), which are capable of self-renewal and myogenic differentiation to form 
hypernucleated myotubes.2, 3 Satellite cells can be also activated under injury and 
pathological conditions and contribute to muscle repair and regeneration.3 Nevertheless, 
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little is known about the effects of bioactive compounds on this multipotent muscle cell 
population and the mechanisms that mediate their effects. 
    Sulforaphane (SFN), an isothiocyanate derived from cruciferous vegetables, is a 
common bioactive compound that has the ability to inhibit type I and II histone 
deacetylase (HDAC), as well as an antioxidant, anti-carcinogenic and chemotherapeutic 
agent.4, 5 In this context, we became interested in the HDAC inhibitor property of SFN. 
In human colorectal cancer cells and prostate epithelial cells, this HDAC inhibition was 
accompanied by increased histone acetylation in global histone H3, H4 and P21 gene 
promoter region, associated with elevated expression of P21 protein.5, 6 In vivo studies 
in SFN-fed mice, HDAC activity was inhibited significantly in various tissues with a 
concomitant increase in global and local histone acetylation.7 In healthy human 
volunteers, oral consumption of SFN-rich broccoli sprouts resulted in a strong HDAC 
inhibition associated with histone hyperacetylation at 3 and 6 h in peripheral blood 
mononuclear cells (PBMC).8 However, as the novel natural HDAC inhibitor, the 
potential epigenetic effects of SFN supplementation on skeletal muscle cells remain 
undiscovered. 
    Myostatin (MSTN; previously called growth differentiation factor 8, GDF8) is a 
member of the transforming growth factor-β (TGF-β) superfamily and a potent inhibitor 
of skeletal muscle growth.9 MSTN can also block satellite cell activation and negatively 
regulate self-renewal of satellite cells.10 It has been identified that follistatin (FST), 
Smad family member 7 (Smad7), Smad specific E3 ubiquitin protein ligase 1 (Smurf1) 
and human small glutamin-rich tetratricopeptide repeat-containing protein (hSGT) are 
involved in the MSTN pathway and inhibit MSTN activity to attenuate MSTN 
signalling.11 In the skeletal muscle field, epigenetic research is emerging only during the 
last years.12 Numerous studies have unveiled that epigenetic alterations, including DNA 
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methylation and histone modifications, are important players in the finely tuned gene 
expression. Small noncoding microRNAs (miRNAs) capable of inducing stable changes 
in gene expression without altering the sequence of genes also contribute to the 
epigenetic landscape.13 Recently, the evidence is accumulating supporting a post-
transcriptional regulatory role for miRNAs in the regulation of MSTN expression. Data 
from Drummond et al. show that a rapid increase of miR-499 expression by essential 
amino acids (EAAs) results in the suppression of MSTN expression in human skeletal 
muscle.14 Allen and Loh have shown that miR-27b targets 3′ untranslated region 
(3′UTR) of MSTN efficiently and may contribute to fast-specific and glucocorticoid-
dependent MSTN expression in skeletal muscle.15 In a trans-regulatory manner, 
transcription factor forkhead box O1 (FoxO1) could bind to the mouse MSTN promoter 
and activate its activity to up-regulate MSTN expression.16 Transcriptional activity of 
human MSTN promoter was strongly enhanced by myocyte enhancer factor 2 (MEF2) 
binding to the element present in the promoter region.17 However, the ability and 
mechanism of SFN epigenetically regulating the MSTN gene in satellite cells are 
unknown.  
    Taking these above observations into account, the objective of this study was to test 
the hypothesis that SFN supplementation influences satellite cells growth and the 
epigenetic mechanisms account for the MSTN gene modulation in response to SFN 
exposure. In the present study, we also employed the typical epigenetic reagents 5-aza-
2′-deoxycytidine (5-aza-dC) and trichostatin A (TSA) compared to SFN treatment. We 
show that, distinguished from TSA, SFN and 5-aza-dC significantly suppress MSTN 
expression and inhibit HDAC activity as well as DNA methyltransferase (DNMT) 
expression in porcine satellite cells. Significantly diminished myoblast determination 
protein (MyoD) enrichment associated with hypoacetylation of the MyoD-binding site 
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in the MSTN promoter results in an epigenetic repression of MSTN. Our findings 
implicate that SFN is able to epigenetically modulate MSTN expression in an in vitro 
muscle stem cell model. If verified and applied to the in vivo models, it may have 
therapeutic benefits in human skeletal muscle disorders and practical value in meat 
production.18 
Results 
Epigenetic reagents affect porcine satellite cell growth and inhibit HDAC activity. 
In this study, we followed cell culture procedure as shown in Fig. 1A.  By design, we 
selected three serial doses (5 µM, 10 µM and 15 µM) of SFN to avoid oxidative stress 
and apoptosis, which occurs at higher concentrations in vitro. 19, 20 Cells were harvested 
48 h after exposure as SFN at 15 µM inhibits HDAC activity and increases histone 
acetylation level in prostate cell lines after 48 h treatment.6 For 5-aza-dC, 10 µM 
concentration was selected because it is the optimal dose to up-regulate both FST 
isoforms (FST288 and FST315).21 For TSA, we used the general concentration 50 nM 
in accordance with previous reports to serve as a positive control.22, 23 Almost all of 
satellite cells were not viable after treatment at day 2 (data not shown), therefore we 
selected day 3 (the myoblast stage) to start the treatment. To examine the cytotoxic 
effects of SFN, TSA and 5-aza-dC treatments on porcine satellite cell growth, we 
determined cell viability (Fig. 1B) and cell proliferation rate (Fig. 1C). No difference in 
cell viability was observed except an increase in the SFN5 group. Only the 5-aza-dC 
and SFN15 groups show reduction of cell proliferation two days after treatment. Given 
that 5-aza-dC is a DNMT inhibitor, we firstly quantified DNMT1 mRNA expression. In 
addition to 5-aza-dC group, DNMT1 transcripts were also remarkably decreased in 
SFN10 and SFN15 groups (Fig. 1D). These results indicate that SFN10 is the optimal 
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group for our experiments. To confirm this and pro-apoptotic effect of SFN, we 
examined caspase 3 and caspase 9 activity which are related to apoptosis induced by 
SFN.24, 25 As shown in Fig. 1E and 1F, caspase activities were inhibited except caspase 
3 in TSA group. Then we selected SFN10 and analysed the HDAC activity in different 
treatments. In line with the previous reports, relative HDAC activities were significantly 
inhibited in all three treatments (Fig. 1G, lower panel). However, global acetyl-histone 
3 and 4 levels were notably decreased in 5-aza-dC and SFN10 groups which differ from 
highly elevated histone acetylation in TSA group (Fig. 1G, upper panel).   
    FST variants were not involved in epigenetic effects of SFN on satellite cells. 
Acting as a potent HDAC inhibitor, TSA can induce the natural MSTN antagonist 
FST.23, 26 Our initial interest was focused on whether SFN demonstrated the similar 
mechanism as TSA. Therefore, we quantified the total FST (Fig. 2A) and FST315 (Fig. 
2B) expression as it is not possible to distinguish another porcine FST isoform FST288 
from FST315 due to the identical sequence. To gain a full profile of influences of SFN 
on FST, other two doses (5 µM and 15 µM) were also used. Nevertheless, up-regulated 
total FST and FST315 were not observed in SFN groups. Considering the DNMT1 
alterations, we plotted 31 CpG sites in the second predicted CpG island (Fig. 2C) of the 
porcine FST 5´-regulatory region and determined the DNA methylation status (Fig. 2D). 
The bisulfite sequencing analysis revealed that all the 31 CpG sites were sparsely 
methylated except some sporadic methylation sites. Taken together, these results 
indicate that FST is not induced by SFN and not involved in SFN effects on porcine 
satellite cells. 
    MSTN and its signalling pathway were inhibited by SFN treatment. MSTN is a 
potent negative regulator of myogenesis, and inactivation of MSTN results in heavy 
muscle growth.27 Given no induction of FST gene expression by SFN, we then 
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reselected MSTN as the candidate gene and determined its expression levels which were 
significantly up-regulated by TSA and down-regulated by 5-aza-dC and SFN (Fig. 3A). 
In this experiment, other two doses of SFN (5 µM and 15 µM) were also used to gain a 
full profile of influences of SFN on MSTN signalling pathway genes. In the skeletal 
muscle, besides FST, Smad7, Smurf1, and hSGT were also identified as inhibitors of 
the MSTN signalling pathway.11 Our results show that hSGT expression was up-
regulated in TSA, 5-aza-dC and SFN15 groups (Fig. 3B). In comparison, Smad (Fig. 
3C) and Smurf1 (Fig. 3D) were only up-regulated in SFN treatment groups. 
Collectively, our observations thus suggested that MSTN itself and its pathway were 
more strongly attenuated by SFN.  
    Predicted miRNAs targeting porcine MSTN 3' UTR region were not involved in 
epigenetic repression of MSTN. miRNAs can silence mRNAs by endonuclease 
cleavage, translational repression and mRNA degradation.28 In order to discover that 
specific miRNAs play regulatory roles in modulating MSTN transcription, we identified 
several miRNA targeting MSTN including miR-21, miR-26a, miR-29abc, miR-181a and 
also obtained experimentally confirmed miRNAs such as miR-27ab15, miR-208b29, 
miR-49930 targeting MSTN from previous publications. MiR-208b and miR-499 
expression was not able to be determined indicated by threshold cycle (Ct) value above 
35 cycles (data not shown). All the miRNAs except miR-27b were remarkably down-
regulated in 5-aza-dC group (Fig. 4A-H). MiR-29a and miR-29b expression 
dramatically decreased in the SFN group (Fig. 4E and Fig. 4F). Only miR-29b exhibited 
notably increased expression in the TSA group (Fig. 4F).  
    MyoD can bind to MSTN promoter to regulate its transcription involving 
histone deacetylation by SFN. Accumulating evidences report that MSTN expression 
could be regulated at transcriptional level. Further analysis of porcine MSTN promoter 
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sequence revealed three putative MyoD binding sites (Fig. 5A). To study the 
transcriptional regulation of the MSTN gene, we next examined whether MyoD would 
be recruited to the promoter regions of MSTN with the use of ChIP. ChIP with antibody 
to MyoD confirmed that endogenous MyoD was present in binding site 1 of MSTN 
promoter region, indicating MyoD interacts with MSTN to regulate MSTN transcription 
(Fig. 5B). In order to examine MyoD availability as the transcription factor, we 
quantified MyoD mRNA and protein level. In accordance with mRNA expression, 
MyoD protein level was significantly elevated in TSA group but decreased in 5-aza-dC 
and SFN10 groups (Fig. 5C). To examine recruitment of MyoD in the MSTN promoter 
region, ChIP was conducted to quantify the relative enrichment. ChIP results 
demonstrated weak recruitment of MyoD in 5-aza-dC and SFN10 group compared to a 
robust recruitment of MyoD in TSA group (Fig. 5D). We were unable to investigate the 
epigenetic regulatory role of DNA methylation in MSTN gene transcription because no 
CpG island in the promoter region of porcine MSTN is available. Moreover, ChIP 
assays were carried out to determine the local histone acetylation status of MyoD 
reponse element. In contrast to dramatic histone hyperacetylation in TSA group, hypo-
acetylation status of histone 3 and 4 was observed in 5-aza-dC and SFN10 groups (Fig. 
6A and 6B). Taken together, these results suggest diminished MyoD and promoter-
specific hypoacetylation could down-regulate MSTN expression at transcription level.. 
Discussion 
For understanding human diseases, pig represents a promising model for biomedical 
research which closely resemble and reflect human biology.31 In this study, we provided 
the first evidence for both SFN and 5-aza-dC as inhibitor of HDAC and DNMT in 
porcine satellite cells, demonstrating different epigenetic mechanisms from TSA. 
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Previous report has described protective effects of SFN treatment on rat skeletal muscle 
damage and oxidative stress,32 but not in the context of HDAC inhibition, and to our 
knowledge this is the first study with SFN in satellite cells. As for 5-aza-dC, there is 
only one report demonstrating human skeletal muscle ryanodine-receptor gene (RYR1) 
transcription was reactivated after treatment with 5-aza-dC,33 but without evidence for 
epigenetic effects of 5-aza-dC on myoblasts. 
    In this study, we investigated the potential epigenetic effects of SFN, TSA and 5-aza-
dC treatments on porcine satellite cell growth. Our results demonstrate that none of 
SFN, 5-aza-dC and TSA influenced the cell viability except SFN at 5 µM. The 
increased cell viability in SFN5 group may indicate the protective effects of SFN on 
satellite cells at lower concentration.32 We also found that cells in 5-aza-dC and SFN15 
groups had a reduction of cell proliferation as compared to negative control. SFN at 10 
µM did not have anti-proliferative effect in the satellite cells. The reduction detected 
after 2 days of treatment may be due to apoptotic response of 5-aza-dC and high-dose of 
SFN.6, 24, 25 We then aimed to investigate the effects of 5-aza-dC on DNA methylation 
status, and how alteration in promoter region methylation affects gene expression. 
DNMT1 expression was determined and found to be significantly suppressed in 5-aza-
dC group, and also in HDAC inhibitor group (SFN10 and SFN15). These results are in 
line with previous studies which report that SFN significantly decreased the expression 
of DNMT1 in response to SFN in breast cancer cells 34 and prostate cancer cells.35 
Gomyo et al.24 and Singh et al.25 reported that 5-aza-dC and SFN-induced apoptosis is 
associated with activation of caspase-3 and caspase-9. SFN dramatically reduced the 
activity of caspase-3 in the cortex and hippocampus after hypoxia-ischemia insult36 and 
was able to counteract rat skeletal muscle damage induced by acute exercise.32 In our 
study, we determined caspase-3 and caspase-9 activities which decreased in 5-aza-dC 
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and SFN10 groups, suggesting that SFN at 10 µM had no pro-apoptotic effect in the 
cells. Multiple studies from cell to human have established that SFN is an effective 
inhibitor of HDAC activity, with evidence for increased global and local histone 
acetylation status.37 However our work shows that SFN and 5-aza-dC are potent 
inhibitor of HDAC activity but decreased global acetylated histones H3 and H4 which 
differ from TSA. Although HDAC inhibitor is expected to induce hyperacetylation, no 
changes in the H3 or H4 acetylation20 and even histone deacetylation38 were also 
observed. Following the very similar treatment conditions as ours (48 h exposure to 15 
µM SFN), Pledgie-Tracy A et al. demonstrate significantly inhibited HDAC activity in 
four human breast cancer cell lines without significant changes in the acetylation of H3 
or H4.20 Another two HDAC inhibitors MS-275 or SK-7068 also effectively inhibited 
cellular HDAC activity in human gastric adenocarcinoma cells (SNU-16) and cause 
decreased H3 or H4 acetylation after 48 h, 72 h and 96 h exposure.38 These findings 
indicate that HDAC inhibitory effects by SFN withdraw and can not last longer to 
maintain histone acetylation in porcine satellite cells. 
    FST is one of the regulatory proteins which is capable of binding directly to MSTN, 
inhibiting its activity and acting as a potent MSTN antagonist.39 Both FST315 and total 
FST expression increased remarkably in TSA and 5-aza-dC group, whereas SFN was 
not able to induce FST. The bisulfite sequencing PCR results just demonstrate some 
sporadic methylated sites. In contrast, a significant increase in FST mRNA expression 
and peptide secretion was detected after 5-aza-dC treatment in human NCI-H295R 
adrenocortical cells, as well as hypomethylation in FST promoter region.21 The present 
study suggest that FST isoforms were not induced by SFN and DNA methylation may 
be not involved in regulation of FST expression. 
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    MSTN inhibits myoblast proliferation and differentiation via a typical TGF-β 
pathway.11 Here we show, for the first time, SFN and 5-aza-dC treatments clearly 
results in attenuated MSTN expression. In keeping with previous report that TSA 
increased MSTN mRNA expression up to 40-fold after treatment for 24 h in C2C12 
myoblast40, a substantial increase in MSTN expression was observed in TSA group. 
These results indicate that these epigenetic reagents affect MSTN expression through 
distinct regulatory mechanisms. In skeletal muscle, several proteins of MSTN signalling 
pathway have been identified as inhibitor of its secretion, activation, or receptor 
binding, including FST, Smad7, Smurf1, and hSGT.11 We determined mRNA 
expression of these negative regulators in different treatments which illustrates 
differential mechanisms involved in the inhibition of MSTN signalling pathway. Up-
regulated FST and hSGT may mainly cause MSTN pathway inhibition in TSA and 5-
aza-dC group. Moreover, enhanced Smad and Smurf1 could participate in such 
inhibition in SFN group. A recent study has shown that TSA induced expression of 
Smad7 in nasal polyp-derived fibroblasts (NPDFs) exposed to TSA (50 nM–400 nM) 
with TGF-β1 for 24 hours.41 Our results show that TSA did not affect expression of 
Smad7 which may be due to the different treatment and cells. No data are available for 
SFN or 5-aza-dC regulating Smad7 expression. As for Smurf1, in contrast to no 
alterations in TSA and 5-aza-dC group, we report firstly that SFN could up-regulate its 
expression. With regard to hSGT, elevated expressions were also firstly observed in 
TSA, 5-aza-dC and SFN15 groups.  
    Recently, decreased expression of miR-136 and miR-500 have been detected in low 
protein fed pigs at finishing stage, which is related to higher MSTN mRNA expression.42 
Here, we demonstrate in porcine satellite cells that miRNAs and MSTN were not 
expressed in a reciprocal manner, suggesting that miRNAs may be not involved in the 
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post-transcriptional regulation of MSTN expression. We speculate that increased 
miRNAs expression in TSA group and decreased miRNAs expression in 5-aza-dC 
group and SFN10 group are highly linked with deregulated permissive mark histone 
acetylation as indicated by global acetylated histone 3 and 4 level (Fig. 1G). Up-
regulation of miR-127 has been observed in T24 human bladder cancer cells treated by 
5-aza-dC and another HDAC inhibitor 4-phenylbutyric acid. Importantly, acetylated 
histone 3 restored miR-127 expression, confirming that histone acetylation 
epigenetically regulates miRNA gene expression.43 Reduced expression of miR-200 
family and miR-205 in bladder cancer cells is also caused by repressive histone marks 
in their promoter region.44 miRNA microarray analysis revealed 22 down-regulated 
miRNA species and 5 up-regulated miRNAs in the breast cancer cell line SKBr3 in 
response to HDAC inhibitor LAQ824.45 
    Our ChIP assay results confirmed that MyoD was recruited to the first putative 
binding site in vivo. We also demonstrated by quantitative PCR that MyoD was 
relatively lower enriched in 5-aza-dC and SFN10 groups, which coincides with the 
lower levels of MyoD mRNA and protein abundance. It can be suggested that MyoD 
could be regulating MSTN gene expression by binding to its response element in the 
promoter region. Spiller MP et al. 46 reported that one of bovine MSTN gene upstream 
regulatory elements appears to be critical for the MSTN promoter activity and that 
MyoD interacts with this binding motif in vitro as well as in vivo to regulate MSTN gene 
expression. More recently, Liu XJ et al. 42 has described that increased histone 3 
acetylation, an activation mark, may account for transcriptional activation of MSTN in 
response to maternal dietary protein at finishing stage in pigs. In our study, compared to 
hyperacetylation of histone 3 and 4 in TSA group, hypoacetylation at the MyoD binding 
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site in 5-aza-dC and SFN10 diminishes binding of MyoD to its element, inactivating 
MSTN transcription.  
    In summary, this is the first demonstration that SFN can regulate MSTN and 
inhibitors of MSTN signalling pathway in porcine satellite cells. Our data revealed the 
following: (i) Both 5-aza-dC and SFN significantly inhibit HDAC activity and DNMT1 
expression. (ii) 5-aza-dC, SFN and TSA demonstrate differential mechanisms to inhibit 
MSTN expression and negative regulators of MSTN pathway. (iii) Deregulated miRNA 
may be not involved in epigenetic repression of MSTN. (iiii) Epigenetic repression of 
MSTN by 5-aza-dC and SFN is associated with the reduced MyoD expression, 
diminished binding of MyoD on MSTN promoter and hypoacetylation in MyoD binding 
site. These results provide new insight into the manipulation of muscle cell phenotypes. 
In the future, it will be interesting to verify the functional roles of SFN in vivo and 
evaluate the potentials for therapy of human muscle diseases and livestock muscle 
growth.  
Materials and Methods 
Porcine satellite cells isolation. The right and left semimembranosus muscles from 6 
purebred Pietrain piglets at 20 days of age were collected for porcine satellite cells 
isolation. Piglets were slaughtered by intracardiac injection of T61 (Intervet). All the 
pigs were kept and slaughtered according to German performance test directions.47 The 
porcine satellite cells isolation procedure was outlined by Mau et al.48 Briefly, the 
muscle samples were quickly removed, sterilized with 70% ethanol, rinsed in cold 
phosphate-buffered saline (PBS), minced, and digested with 0.25% trypsin (27250-018, 
Invitrogen) for 1 h at 37°C with continuous shaking. Digestion was stopped by 20% 
fetal bovine serum (FBS, 10270106, Invitrogen). The resulting cell suspension was then 
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filtered through 2×70 µm (352350, BD Falcon) and 1×40 µm cell strainer (352340, BD 
Falcon). Satellite cells were enriched by using a Percoll (P1644, Sigma-Aldrich) 
gradient (90%, 40%, 25%) centrifugation. Then the enriched satellite cells were 
collected and diluted with minimum essential medium α (MEMα, M0894, Sigma-
Aldrich) supplemented with 4 mM glutamine (25030, Invitrogen), 100 IU/ml penicillin, 
100 µg/ml streptomycin (15140, Invitrogen), 2.5 µg/ml fungizone (15290, Invitrogen) 
and 10% FBS. After counting by a hemocytometer, aliquots of the cells were frozen in 
liquid nitrogen until making a pool. Before starting experiments, a uniform pool was 
made from all aliquots obtained from several isolation procedures.  
    Cell culture, cell viability and cell proliferation rate. Aliquots of uniform porcine 
satellite cells pool were thawed and reseeded in gelatin-coated (0.1%, G1890, Sigma-
Aldrich) CytoOne cell culture dishes or flasks (USA Scientific, Inc.). All incubations 
were performed at 37°C under a humidified atmosphere of 5% CO2 in air. The medium 
was changed every other day and all experiments were repeated for three times with 
duplicates. Details of cell culture procedure are shown in Fig. 1A. At day 3, the cells 
were exposed to DMSO (7029.1, Carl Roth GmbH), TSA (T8552, Sigma-Aldrich), 5-
aza-dC (A3656, Sigma-Aldrich), and SFN (S8044, LKT) for 48h in MEMα with 10% 
FBS (growth medium, GM). Treatments were categorized into 0.04% DMSO (vehicle 
control, equal 0.04% DMSO present in other reconstituted chemicals), TSA (50 nM 
TSA), AZA (10 µM 5-aza-dC), SFN5 (5 µM SFN), SFN10 (10 µM SFN) and SFN15 
(15 µM SFN) groups. 
    WST-1 kit (10008883, Cayman Chemical) was used to quantify cell viability and cell 
proliferation rate according to the manufacturer's instruction. Cell viability was 
measured after treatment. Cell proliferation rate was determined after two additional 
days in GM without treatment.  
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    Measurement of cell apoptosis. Cells were reseeded in gelatin coated plates, 
followed by a 48 h treatment. Caspase-3 and 9 activity in cultures were measured using 
the caspase-3/CPP32 Colorimetric Assay Kit (K106-25, Biovision) and caspase-9 
Colorimetric Assay Kit (K119-25, Biovision), according to the manufacturer's 
instructions. Samples were read at 405 nm in a microtiter plate reader (Molecular 
Devices). 
    In vitro HDAC activity assay and histone isolation. After treatment at day 5, in 
vitro HDAC activity was determined using the Color-de-Lys HDAC colorimetric 
activity assay kit (BML-AK501-0001, Enzo Life Sciences), following the protocol 
described by the manufacturer. Briefly, approximately 10 µg nuclear extract for each 
sample was incubated with the HDAC assay buffer and the HDAC colorimetric 
substrate for 30 min at 37°C. Lysine developer was then added, and the samples were 
incubated at 37°C for another 30 min. Samples were read at 405 nm using a microtiter 
plate reader.  
    Satellite cells were cultured without or with different treatment for 48 h. Histone 
proteins were then isolated by EpiQuik Total Histone Extraction Kit (OP-0006, 
Epigentek) according to the manufacturer' manual, followed by Western blotting 
analysis of acetylated histone 3 and histone 4.  
    Prediction of miRNAs  targeting MSTN. To determine the differentially expressed 
miRNAs targeting MSTN, we used two miRNA target prediction algorithms: 
MicroCosm Targets Version 5 (http://www.ebi.ac.uk/enright-
srv/microcosm/htdocs/targets/v5/), and TargetScan49. The putative binding sites were 
further verified by RNAHybrid (http://bibiserv.techfak.uni-
bielefeld.de/rnahybrid/submission.html) and RNA22 
(http://cbcsrv.watson.ibm.com/rna22.html). 
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    qRT-PCR of miRNA and mRNA. Total RNAs including miRNAs were isolated 
using miRNeasy Mini Kit (217004, Qiagen) and reverse transcribed using miScript II 
RT Kit (218161, Qiagen). Total RNAs for mRNA expression were isolated and reverse 
transcribed as described previously.4 Primers were designed using the online Primer3 
program.50 Quantitative real time PCR (qRT-PCR) was performed with a StepOnePlus 
Real-Time PCR System (Applied Biosystems) using miScript SYBR Green PCR Kit 
(218073, Qiagen) and iTaq SYBR Green Supermix with ROX (172-5850, Bio-Rad) for 
the detection of miRNAs and mRNAs, respectively. Primers used for the detection of 
miRNA and mRNA are listed in Table 1. qRT-PCR data were analysed using the 2-∆∆Ct 
method51 with hypoxanthine phosphoribosyltransferase 1 (HPRT1)52 for mRNAs and 
18S ribosomal RNA for miRNAs as endogenous references. 
    Western blotting analysis. A protocol for this procedure was described previously. 
53
 For acetylated histone 3 and histone 4, equal protein was loaded and confirmed by 
ponceau S staining. For MyoD, blots were probed with glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) antibody to correct for differences in protein loading. 
Western blotting was carried out with the following primary antibodies: MyoD (1:1000, 
sc-31940 X, Santa Cruz), acetyl-histone H3 (0.05 µg/ml, 06-599, Millipore), acetyl-
histone H4 (1:1000, 06-866, Millipore), GAPDH (1:3000, sc-20357, Abcam), followed 
by horseradish peroxidase (HRP)-conjugated secondary antibodies (donkey anti-goat, 
1:3000, sc-2020, Santa Cruz; goat anti-rabbit, 1:2000, sc-2004, Santa Cruz). Finally, the 
specific signals were detected by chemiluminescence using the SuperSignal West Pico 
Chemiluminescent Substrate (34077, Thermo Scientific). Images were acquired by 
Quantity One 1-D analysis software (Bio-Rad).  
    DNA methylation study. The 5´-regulatory region of FST (GenBank: M19529) was 
submitted to the online program Methprimer54 to identify the CpG islands. Genomic 
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DNA (1 µg) was subjected to bisulfite modification using EZ DNA Methylation-Direct 
Kit (D5020, Zymo Research) according to the manufacturer’s protocol. The FST 5´-
regulatory region containing CpG island was amplified by nested PCR with FST-met-
nest primer pairs (Table 1) designed using PerlPrimer55 and Methyl Primer Express 
Software v1.0 (Applied Biosystems Inc.). PCR products were purified with QIAquick 
PCR purification kit (28104, Qiagen) and then subcloned into the pGEM T-easy vector 
(A1360, Promega). A minimum of six different positive clones were randomly selected 
for sequencing with M13 primers performed by the CEQ8000 sequencer system 
(Beckman Coulter). The final sequence results were processed by QUMA software.56 
Sequences with a conversion rate below 90% were excluded from analysis. 
    ChIP assays. The chromatin immunoprecipitation (ChIP) assay kit (17-295, 
Millipore) was used in accordance with the manufacturer’s instructions. Soluble 
chromatin was immunoprecipitated with anti-MyoD (sc-31940 X, Santa Cruz), anti-
acetyl-histone H3 (06-599, Millipore) or anti-acetyl-histone H4 (06-866, Millipore). 
Immunoprecipitates were subjected to quantitative PCR with MSTN promoter specific 
primers spanning the putative binding sites of interest (Table 1). As a negative control, a 
primer pair of MyoD binding site free region was used to amplify another genomic 
region that was not expected to interact with MyoD. Antibodies against RNA 
polymerase II (sc-899 X, Santa Cruz) and normal rabbit IgG (2729S, Cell signaling 
Technology) were used as a positive and a negative control in the assay, respectively. 
PCR products were separated on a 2% agarose gel stained with ethidium bromide for 
visualization. With the percent input method, signals obtained from the ChIP are 
divided by signals obtained from an input sample. Quantitative PCR data were 
normalized to and expressed as % of input.  
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    Statistical analysis. Pairwise comparisons were made between treatment groups and 
the vehicle-treated control, using Student’s t test. The data were expressed as means ± 
standard deviations (SD) and (*) P < .05, (**) P <.01, (***) P <.001 were set 
statistically significant.   
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Table 1 List of primer sequences used in this study. 
Applications and targets Primers sequence (5´-3´) GenBank ID 
DNMT1  F: GCGGGACCTACCAAACAT 
R: TTCCACGCAGGAGCAGAC 
DQ060156 
Myostatin  F: GATTATCACGCTACGACGGA 
R: CCTGGGTTCATGTCAAGTTTC 
AY448008 
FST315 F: AGTGACAATGCCACCTACGC 
R: CCTCGGTGTCTTCTGAAATGG 
M19529.1 
FSTtotal F: AAAACCTACCGCAACGAATG 
R: CAGAAAACATCCCGACAGGT 
NM_001003662 
MyoD F: TGCAAACGCAAGACCACTAA 
R: GCTGATTCGGGTTGCTAGAC 
GU249575 
Smurf1 F: CAGCGTCTGGATCTATGCAA 
R: CTAACAGGCCTCTGCAGTCC 
XM_003354460 
Smad7 F: CCAACTGCAGACTGTCCAGA 
R: CAGGCTCCAGAAGAAGTTGG 
HM803236 
hSGT F: GACCCCGACAATGAGACCTA 
R: TGATGCCATGCTCATAAAGC 
NM_001244392 
qRT-PCR 
for mRNA 
expression 
HPRT1 F: AACCTTGCTTTCCTTGGTCA 
R: TCAAGGGCATAGCCTACCAC 
NM_001032376.2 
ssc-miR-21 F: GCACCTAGCTTATCAGAC  
ssc-miR-26a F: TTCAAGTAATCCAGGATAGGCT  
ssc-miR-27a F: TTCACAGTGGCTAAGTTCTGC  
qRT-PCR 
for miRNA 
expression 
ssc-miR-27b F: TTCACAGTGGCTAAGTTCTGC  
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ssc-miR-29a F: CTAGCACCATCTGAAATCGGTTA  
ssc-miR-29b F: TAGCACCATTTGAAATCAGT  
ssc-miR-29c F: TAGCACCATTTGAAATCGGTTA  
ssc-miR-181a F: AACATTCAACGCTGTCGGTGAGTT  
18S F: ACGGACAGGATTGACAGATT  
FST-met-
nest1 
F: TATTGGGAGATYGTTTATYGTAAAT 
R: CTTAAAACRAACCATTCT 
M19529 
Bisulfite 
sequencing 
PCR 
FST-met-
nest2 
F: AGATTTTYGTTTAGATTTAAAG 
R: CARCAAATAATTCCARCAAA 
M19529 
MyoD-BSF F: TGAATCAGCTCACCCTTGACT 
R: ATGATTGGCTCTTGCTCCAC 
AY527152 
MyoD-BS1 F: CCAGACCTTACCCCAAATCC 
R: GCAGTTTGCCTCAGATTTCC 
AY527152 
MyoD-BS2 F: CAGTTGAAAACTGAGCACGA 
R: TTTAGACAAACATTTGAGGAAAAA 
AY527152 
ChIP assay 
MyoD-BS3 F: GTGGAGCAAGAGCCAATCAT 
R: ACAACTTGCCACACCAGTGA 
AY527152 
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Figure 1. Epigenetic reagents affect porcine satellite cell culture and inhibit HDAC 
activity. (A) Scheme of porcine satellite cell culture and treatment procedure. (B) Cells 
were treated following the procedure as shown in (A). Cell viability was determined by 
WST-1 kit. (C) After removal of epigenetic chemicals, cells were allowed to proliferate 
for 2 days. Then cell proliferation rate was assessed by WST-1 kit. (D) DNMT1 relative 
mRNA expression was quantified by qRT-PCR after treatments. (E) and (F) Caspase-3 
and 9 activity in cultures were evaluated using the caspase-3/CPP32 Colorimetric Assay 
Kit and caspase-9 Colorimetric Assay Kit, respectively. (G) Relative HDAC activity 
(lower panel) was examined using the Color-de-Lys HDAC colorimetric activity assay 
kit. Equal amounts of isolated histone protein were subjected to Western blotting 
analysis to investigate acetylated histone 3 and 4 levels (upper panel). The results 
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represent the mean ± standard deviations (SD) of three independent experiments each 
performed in duplicate (* P < 0.05; ** P < 0.01; *** P < 0.001). 
 
Figure 2. FST variants were not involved in epigenetic effects of SFN on satellite cell. 
(A) and (B) Total FST and FST315 mRNA levels were quantified by qRT-PCR after 
treatments. The results represent the mean ± standard deviations (SD) of three 
independent experiments each performed in duplicate (** P < 0.01; *** P < 0.001). (C) 
CpG islands in the FST promoter region were predicted by MethPrimer online (upper 
panel). Thirty-one numbered CpG dinucleotides were mapped in genomic sequence 
(lower panel). (D) DNA methylation status within CpG island 2 spanning putative 
activating transcription factor (ATF)/cAMP response element binding protein (CREB) 
binding site was quantified by bisulfite sequencing PCR. A minimum of six positive 
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clones were randomly picked for sequencing with M13 primers. Sequencing results 
were visualized by QUMA software. Unfilled (white) circles correspond to 
unmethylated Cs and filled (black) circles correspond to methylated Cs. 
 
Figure 3. MSTN and its signalling pathway were inhibited by SFN treatment. qRT-
PCR was carried out to quantify MSTN (A), hSGT (B), Smad7 (C) and Smurf1 (D) 
mRNA level. The results represent the mean ± standard deviations (SD) of three 
independent experiments each performed in duplicate (** P < 0.01; *** P < 0.001). 
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Figure 4. Predicted miRNAs targeting porcine MSTN 3'UTR region were not 
implicated in MSTN epigenetic repression. qRT-PCR was undertaken to quantify miR-
21 (A), miR-26a (B), miR-27a (C), miR-27b (D), miR-29a (E), miR-29b (F), miR-29c 
(G) and miR-181a (H) expression level. The results represent the mean ± standard 
deviations (SD) of three independent experiments each performed in duplicate (* P < 
0.05; ** P < 0.01; *** P < 0.001). 
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Figure 5. MyoD expression and occupancy in the MSTN promoter were significantly 
diminished by SFN and 5-aza-dC. (A) Schematic representation of three potential 
MyoD binding sites and PCR-amplified fragments located in MSTN promoter region. 
(B) ChIP was performed for MyoD recruitment to MSTN promoter following 48 h 
treatment. Soluble chromatin was immunoprecipitated with antibodies against rabbit 
IgG, RNA pol II and MyoD. Immunoprecipitates were subjected to PCR with primer-
pairs for each amplicon indicated in (A). The sequences of primer pairs are described in 
Table 1. As a negative control, a set of primers were used to amplify binding free region 
that was not expected to interact with the MyoD. Amplification products were resolved 
in 2% agarose gel stained with ethidium bromide. M, DNA marker. BF, MyoD binding 
free region. BS1-3, MyoD binding site 1-3. (C) MyoD mRNA (lower part) and protein 
(upper part) expression were quantified by qRT-PCR and Western blotting, 
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respectively. The results represent the mean ± standard deviations (SD) of three 
independent experiments each performed in duplicate (*** P < 0.001). (D) Abundance 
of MyoD binding in BS1 of MSTN promoter region was determined by quantitative 
PCR following ChIP assay with MyoD antibody (lower part). Data are shown as a ratio 
to the input DNA. The PCR products were generated and visualized in 2% agarose gel 
(upper part). M, DNA marker. BF, MyoD binding free region. BS1, MyoD binding site 
1.  
 
Figure 6. SFN and 5-aza-dC caused weak enrichment of acetylated histones around the 
MSTN BS1. (A) Acetyl-histone 3 was examined by quantitative PCR following ChIP 
assay with MyoD antibody (right part). Amplification products were visualized in a 2% 
agarose gel (left part). (B) Acetyl-histone 4 was determined by quantitative PCR 
following ChIP assay with MyoD antibody (right part). PCR products were visualized 
in a 2% agarose gel (left part). Data are normalized to the amount of input chromatin. 
M, DNA marker. BS1, MyoD binding site 1.  
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